- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Full active substances list
Pharmaceuticals - Community Register
Full list of products by active substance: 5
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Active substance | Brand name | EU Number | Human or veterinary | Procedure type | details |
505 amino acid protein, corresponding to amino acids 2-506 of the wild-type human histidyl-tRNA synthetase | EU/3/17/1831 | Human | Orphan designation | details | |
,, | EU/3/15/1448 | Human | Orphan designation | details | |
5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin | EU/3/15/1470 | Human | Orphan designation | details | |
[5,10,15,20-tetrakis(4-carboxyphenyl)-21H,23H-porphine]manganese(III) chloride | EU/3/16/1809 | Human | Orphan designation | details | |
5-10-Methylene-tetrahydrofolate | EU/3/03/143 | Human | Orphan designation | details | |
5,10-methylene-tetrahydrofolic acid | EU/3/04/221 | Human | Orphan designation | details | |
5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride | EU/3/13/1136 | Human | Orphan designation | details | |
,, | EU/3/11/892 | Human | Orphan designation | details | |
5-(2,6-Difluoro-phenoxy)-3(R,S)-{2(S)-[2(S)-(3-methoxycarbonyl-2(S)-{3-methyl-2(S)-[(quinoline-2-carbonyl)-amino]-butyrylamino}-propionylamino)-3-methyl-butyrylamino]-propionylamino}-4-oxo-pentanoic acid methyl ester | EU/3/06/403 | Human | Orphan designation | details | |
5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride | EU/3/16/1770 | Human | Orphan designation | details | |
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | EU/3/17/1830 | Human | Orphan designation | details | |
5,5'-(4-(trifluromethyl)benzylazanediyl)bis(methylene)diquinolin-8-ol | EU/3/14/1408 | Human | Orphan designation | details | |
[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride | EU/3/15/1457 | Human | Orphan designation | details | |
5,6,7,8-Tetrahydrobiopterin | EU/3/03/163 | Human | Orphan designation | details | |
5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride | EU/3/15/1497 | Human | Orphan designation | details | |
5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine | EU/3/14/1391 | Human | Orphan designation | details | |
5-amino-1-(2-methyl-1H-benzo[d]imidazol-5-yl)-1H-pyrazol-4-yl 1H-indol-2-yl ketone mono[(S)-2-hydroxysuccinate] | EU/3/17/1916 | Human | Orphan designation | details | |
[5-amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone | EU/3/14/1323 | Human | Orphan designation | details | |
5-Aminolaevulinic acid | Ameluz | EU/1/11/740 | Human | Centralised | details |
5-aminolevulinic acid | 5-aminolevulinic acid | Human | Referral | details | |
,, | EU/3/16/1811 | Human | Orphan designation | details | |
5-aminolevulinic acid hydrochloride | Gliolan | EU/1/07/413 | Human | Centralised | details |
,, | EU/3/02/121 | Human | Orphan designation | details | |
5'-ASCSASTSCSASGSTSCSTSGSASUSASASGSCSTSA-3' | EU/3/15/1451 | Human | Orphan designation | details | |
5-bromo-N-(prop-2-yn-1-yl)-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diamine | EU/3/14/1392 | Human | Orphan designation | details | |
5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine | Human | Orphan Refusal | details | ||
5’-CTG CCA CGT TCT CCT GC-(2’ methoxy)A-(2’ methoxy)C-(2’ methoxy)C-3’ | EU/3/04/203 | Human | Orphan designation | details | |
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole | EU/3/08/591 | Human | Orphan designation | details | |
5-hydroxymethyl-2-furfural | EU/3/15/1441 | Human | Orphan designation | details | |
5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt | EU/3/03/182 | Human | Orphan designation | details | |
5'-O-(trans-9''-octadecenoyl)-1-beta-D-2'-deoxy-2',2'-difluorocytidine | EU/3/09/680 | Human | Orphan designation | details | |
5'-O-(trans-9'-octadecenoyl)-1-β-D-arabinofuranosyl cytosine | EU/3/07/476 | Human | Orphan designation | details | |
(5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one | EU/3/14/1270 | Human | Orphan designation | details | |
5(S)-(2'-hydroxy ethoxy)-20(S)- camptothecin | EU/3/07/450 | Human | Orphan designation | details | |
(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide | EU/3/15/1576 | Human | Orphan designation | details |